The Patent Finder

Addex Pharma, S.A.

Also on record
Records under this name other than the patents Addex Pharma, S.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 8 patents it holds.

Back to Addex Pharma, S.A.

PatentTitleStatus Expires Confidence
US 8,101,637Alkynyl derivatives as modulators of metatropic glutamate receptors
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,779,129Novel Triazinedione Derivatives as Gabab Receptor Modulators
Lapsed on the fee record
Ended Jul 15, 2026 · High confidence
Lapsed on the fee recordEnded Jul 15, 2026High confidence
US 9,765,091NOVEL TETRAHYDROPYRAZOLO [3,4-b] AZEPINE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS
Formerly held
Lapsed on the fee record
Ended Sep 19, 2025 · High confidence
Lapsed on the fee recordEnded Sep 19, 2025High confidence
US 8,674,106Alkynyl derivatives as modulators of metabotropic glutamate receptors
Term ended
Ended no later than Jun 17, 2025 · From the USPTO record
Term endedEnded no later than Jun 17, 2025From the USPTO record
US 8,883,826Alkynyl derivatives as modulators of metabotropic glutamate receptors
Term ended
Term ended Jun 17, 2025 · From the USPTO record
Term endedTerm ended Jun 17, 2025From the USPTO record
US 8,399,493Pyridinone derivatives and their use as positive allosteric modulators of mGluR2-receptors
Formerly held
Lapsed on the fee record
Ended Mar 19, 2025 · From the USPTO record
Lapsed on the fee recordEnded Mar 19, 2025From the USPTO record
US 9,266,8341, 4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of MGLUR2-receptors
Lapsed on the fee record
Ended Feb 23, 2024 · From the USPTO record
Lapsed on the fee recordEnded Feb 23, 2024From the USPTO record
US 9,226,9301,2,4-triazolo [4,3-a] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders
Lapsed on the fee record
Ended Jan 5, 2024 · From the USPTO record
Lapsed on the fee recordEnded Jan 5, 2024From the USPTO record
US 9,085,5777-aryl-1,2,4-triazolo[4,3-A]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
Lapsed on the fee record
Ended Jul 21, 2023 · From the USPTO record
Lapsed on the fee recordEnded Jul 21, 2023From the USPTO record
US 8,946,2051,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
Lapsed on the fee record
Ended Feb 3, 2023 · From the USPTO record
Lapsed on the fee recordEnded Feb 3, 2023From the USPTO record
10 of 32 patents shown.
Pro members see all 32.
Pro members: see all 32 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited